244 related articles for article (PubMed ID: 15463886)
21. Antimicrobial peptides in saliva of children with severe early childhood caries.
Colombo NH; Ribas LF; Pereira JA; Kreling PF; Kressirer CA; Tanner AC; Duque C
Arch Oral Biol; 2016 Sep; 69():40-6. PubMed ID: 27232359
[TBL] [Abstract][Full Text] [Related]
22. An investigation of human beta-defensins and cathelicidin expression in patients with pterygium.
Karadag R; Bayram N; Oguztuzun S; Bayramlar H; Bozer B; Simsek G; Rapuano CJ
Arq Bras Oftalmol; 2017; 80(5):277-280. PubMed ID: 29160535
[TBL] [Abstract][Full Text] [Related]
23. Salivary human beta-defensins and cathelicidin levels in relation to periodontitis and type 2 diabetes mellitus.
Yilmaz D; Topcu AO; Akcay EU; Altındis M; Gursoy UK
Acta Odontol Scand; 2020 Jul; 78(5):327-331. PubMed ID: 31980002
[No Abstract] [Full Text] [Related]
24. Production of beta-defensins by human airway epithelia.
Singh PK; Jia HP; Wiles K; Hesselberth J; Liu L; Conway BA; Greenberg EP; Valore EV; Welsh MJ; Ganz T; Tack BF; McCray PB
Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14961-6. PubMed ID: 9843998
[TBL] [Abstract][Full Text] [Related]
25. Elevated BALF concentrations of alpha- and beta-defensins in patients with pulmonary alveolar proteinosis.
Mukae H; Ishimoto H; Yanagi S; Ishii H; Nakayama S; Ashitani J; Nakazato M; Kohno S
Respir Med; 2007 Apr; 101(4):715-21. PubMed ID: 17000097
[TBL] [Abstract][Full Text] [Related]
26. Capsular antigen fraction 1 and Pla modulate the susceptibility of Yersinia pestis to pulmonary antimicrobial peptides such as cathelicidin.
Galván EM; Lasaro MA; Schifferli DM
Infect Immun; 2008 Apr; 76(4):1456-64. PubMed ID: 18227173
[TBL] [Abstract][Full Text] [Related]
27. Innate immune peptide LL-37 displays distinct expression pattern from beta-defensins in inflamed gingival tissue.
Hosokawa I; Hosokawa Y; Komatsuzawa H; Goncalves RB; Karimbux N; Napimoga MH; Seki M; Ouhara K; Sugai M; Taubman MA; Kawai T
Clin Exp Immunol; 2006 Nov; 146(2):218-25. PubMed ID: 17034573
[TBL] [Abstract][Full Text] [Related]
28. Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Bronchoalveolar lavage for the evaluation of anti-inflammatory treatment (BEAT) study group.
Ratjen F; Rietschel E; Griese M; Ballmann M; Kleinau I; Döring G; Reinhardt D; Paul K
Eur Respir J; 2000 Jan; 15(1):141-5. PubMed ID: 10678636
[TBL] [Abstract][Full Text] [Related]
29. [Beta-defensins in plasma and bronchoalveolar lavage fluid in patients with non-tuberculous mycobacterium infection].
Ashitani J; Kumamoto K; Hiratsuka T; Mukae H; Nakazato M; Matsukura S
Nihon Kokyuki Gakkai Zasshi; 2001 Jan; 39(1):12-6. PubMed ID: 11296379
[TBL] [Abstract][Full Text] [Related]
30. The RLR/NLR expression and pro-inflammatory activity of tissue mast cells are regulated by cathelicidin LL-37 and defensin hBD-2.
Agier J; Różalska S; Wiktorska M; Żelechowska P; Pastwińska J; Brzezińska-Błaszczyk E
Sci Rep; 2018 Aug; 8(1):11750. PubMed ID: 30082780
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D represses rhinovirus replication in cystic fibrosis cells by inducing LL-37.
Schögler A; Muster RJ; Kieninger E; Casaulta C; Tapparel C; Jung A; Moeller A; Geiser T; Regamey N; Alves MP
Eur Respir J; 2016 Feb; 47(2):520-30. PubMed ID: 26585423
[TBL] [Abstract][Full Text] [Related]
32. Antibacterial peptides in bronchoalveolar lavage fluid.
Schnapp D; Harris A
Am J Respir Cell Mol Biol; 1998 Sep; 19(3):352-6. PubMed ID: 9730862
[TBL] [Abstract][Full Text] [Related]
33. Cathelicidin LL-37 in bronchoalveolar lavage and epithelial lining fluids from healthy individuals and sarcoidosis patients.
Golec M; Reichel C; Lemieszek M; Buczkowski J; Mackiewicz B; Skórska C; Dutkiewicz J; Góra A; Ziesche R; Milanowski J
J Biol Regul Homeost Agents; 2014; 28(1):73-9. PubMed ID: 24750793
[TBL] [Abstract][Full Text] [Related]
34. Cholesteryl esters are elevated in the lipid fraction of bronchoalveolar lavage fluid collected from pediatric cystic fibrosis patients.
Ma DC; Yoon AJ; Faull KF; Desharnais R; Zemanick ET; Porter E
PLoS One; 2015; 10(4):e0125326. PubMed ID: 25919295
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial peptides are present in immune and host defense cells of the human respiratory and gastrointestinal tracts.
Wah J; Wellek A; Frankenberger M; Unterberger P; Welsch U; Bals R
Cell Tissue Res; 2006 Jun; 324(3):449-56. PubMed ID: 16501999
[TBL] [Abstract][Full Text] [Related]
36. Deletion of mtrC in Haemophilus ducreyi increases sensitivity to human antimicrobial peptides and activates the CpxRA regulon.
Rinker SD; Trombley MP; Gu X; Fortney KR; Bauer ME
Infect Immun; 2011 Jun; 79(6):2324-34. PubMed ID: 21444663
[TBL] [Abstract][Full Text] [Related]
37. Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis.
Noah TL; Murphy PC; Alink JJ; Leigh MW; Hull WM; Stahlman MT; Whitsett JA
Am J Respir Crit Care Med; 2003 Sep; 168(6):685-91. PubMed ID: 12829455
[TBL] [Abstract][Full Text] [Related]
38. Increased serum antimicrobial peptide LL-37 and HBD-2 combined with 25-hydroxyvitamin D3 deficiency in infants with pertussis.
Chen S; Ye W; Zheng W; Xu Z; Chen Y; Jin L
J Infect Dev Ctries; 2020 Oct; 14(10):1164-1169. PubMed ID: 33175712
[TBL] [Abstract][Full Text] [Related]
39. Identification and quantification of innate immune system mediators in human breast milk.
Armogida SA; Yannaras NM; Melton AL; Srivastava MD
Allergy Asthma Proc; 2004; 25(5):297-304. PubMed ID: 15603202
[TBL] [Abstract][Full Text] [Related]
40. Inducibility of HBD-2 in acute burns and chronic conditions of the lung.
Milner SM; Cole A; Ortega MR; Bakir MH; Gulati S; Bhat S; Ganz T
Burns; 2003 Sep; 29(6):553-5. PubMed ID: 12927979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
